InsiderSignal.AI

InsiderSignal.ai

UTHR - United Therapeutics Corp

Insider Sale by Causey Christopher (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

6 days ago, Causey Christopher, serving as Dir at United Therapeutics Corp (UTHR), sold 1,300 shares at $604.64 per share, for a total transaction value of $786,032.00. Following this transaction, Causey Christopher now holds 4,190 shares of UTHR.

This sale represents a 24.00% decrease in Causey Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 30, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Causey Christopher

Dir

Christopher Causey is a director at United Therapeutics Corporation (UTHR), a biotechnology company focused on innovative therapies for pulmonary arterial hypertension and organ transplantation technologies, where he has served since 2003 and currently chairs the Nominating and Governance Committee.[[1]](https://www.gurufocus.com/insider/74250/christopher-causey)[[2]](https://wooster.edu/2023/11/09/christopher-causey-85-helps-drive-major-advancements-in-organ-transplantation-through-board-of-directors-leadership/)[[7]](https://unither.com/about-us/leadership) He owns approximately 4,190 shares of UTHR stock as of February 2026, valued at over $2 million, following recent sales including 1,000 shares on February 25, 2026, at $520 each under a Rule 10b5-1 plan.[[3]](https://www.marketbeat.com/instant-alerts/united-therapeutics-nasdaquthr-director-christopher-causey-sells-1000-shares-2026-02-25/)[[5]](https://www.stocktitan.net/sec-filings/UTHR/form-4-united-therapeutics-corp-insider-trading-activity-8b44623b779d.html)[[6]](https://www.tradingview.com/news/tradingview:584982f0deee6:0-united-therapeutics-director-sells-1-000-shares/) Causey graduated from the College of Wooster in 1985 and earned an M.B.A. from The George Washington University.[[2]](https://wooster.edu/2023/11/09/christopher-causey-85-helps-drive-major-advancements-in-organ-transplantation-through-board-of-directors-leadership/) His career in healthcare includes senior executive roles at Blue Cross and Blue Shield of Minnesota and Allina Health, before founding Causey Consortium, a healthcare strategy and marketing consulting firm, in 2002.[[2]](https://wooster.edu/2023/11/09/christopher-causey-85-helps-drive-major-advancements-in-organ-transplantation-through-board-of-directors-leadership/) He has been affiliated with United Therapeutics since its founding in 1996 and contributes to advancements in xenotransplantation, such as xenohearts and xenokidneys.[[2]](https://wooster.edu/2023/11/09/christopher-causey-85-helps-drive-major-advancements-in-organ-transplantation-through-board-of-directors-leadership/)

View full insider profile →

Trade Price

$604.64

Quantity

1,300

Total Value

$786,032.00

Shares Owned

4,190

Trade Date

Monday, March 30, 2026

6 days ago

SEC Filing Date

Tuesday, March 31, 2026

Filed 1 day after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About United Therapeutics Corp

Company Overview

No company information available
View news mentioning UTHR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5255160

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime